| Eye Site Of Bluffton Llc | |
|
104 Buckwalter Pkwy, Unit 1 C, Bluffton, SC 29910-4131 | |
| (843) 757-9588 | |
| (843) 757-9589 |
| Full Name | Eye Site Of Bluffton Llc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 104 Buckwalter Pkwy, Bluffton, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902988173 | NPI | - | NPPES |
| DA9667 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Robert M Szypczak |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1841220878 PECOS PAC ID: 5890744155 Enrollment ID: I20050114000406 |
News Archive
Every year waste treatment facilities in the United States process more than eight million tons of semi-solid sewage called biosolids - about half of which is recycled into fertilizer and spread on crop land.
Today in the journal Nature prominent researchers from Canada, Europe and the U.S. have made a powerful call to major funding agencies, asking them to commit to establishing a global genomic data commons in the cloud that could be easily accessed by authorized researchers worldwide.
Politico reports on how Rep. Paul Ryan's record on reproductive issues - including co-sponosring a "personhood amendment" that would declare a fertilized egg to be a person, and voting to defund Planned Parenthood - could widen President Barack Obama's lead among women. Meanwhile, a controversial comment about rape by a GOP candidate running for Senate in Missouri has stirred anger and angst.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed dermatologists view Abbott/Eisai's Humira as the most efficacious therapy for the treatment of moderate to severe psoriasis. Thirty-two percent of surveyed dermatologists selected Humira as the most efficacious, followed by Centocor Ortho Biotech/Merck/Mitsubishi Tanabe's Remicade. The current sales leader Amgen/Pfizer/Takeda's Enbrel was selected as the most efficacious therapy by only 23 percent of dermatologists surveyed.
PRISM Pharma Co., Ltd., a drug discovery company focused on developing small molecule technologies that modulate protein-protein interactions, today announced the close of an approximately $15 million (approximately ¥1.4 billion) Series C financing.
› Verified 6 days ago
| Provider Name | Jennifer R Switak |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1417050790 PECOS PAC ID: 3476586041 Enrollment ID: I20050914000633 |
News Archive
Every year waste treatment facilities in the United States process more than eight million tons of semi-solid sewage called biosolids - about half of which is recycled into fertilizer and spread on crop land.
Today in the journal Nature prominent researchers from Canada, Europe and the U.S. have made a powerful call to major funding agencies, asking them to commit to establishing a global genomic data commons in the cloud that could be easily accessed by authorized researchers worldwide.
Politico reports on how Rep. Paul Ryan's record on reproductive issues - including co-sponosring a "personhood amendment" that would declare a fertilized egg to be a person, and voting to defund Planned Parenthood - could widen President Barack Obama's lead among women. Meanwhile, a controversial comment about rape by a GOP candidate running for Senate in Missouri has stirred anger and angst.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed dermatologists view Abbott/Eisai's Humira as the most efficacious therapy for the treatment of moderate to severe psoriasis. Thirty-two percent of surveyed dermatologists selected Humira as the most efficacious, followed by Centocor Ortho Biotech/Merck/Mitsubishi Tanabe's Remicade. The current sales leader Amgen/Pfizer/Takeda's Enbrel was selected as the most efficacious therapy by only 23 percent of dermatologists surveyed.
PRISM Pharma Co., Ltd., a drug discovery company focused on developing small molecule technologies that modulate protein-protein interactions, today announced the close of an approximately $15 million (approximately ¥1.4 billion) Series C financing.
› Verified 6 days ago
| Provider Name | Rinku Patel |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1073948212 PECOS PAC ID: 2769769215 Enrollment ID: I20200624002307 |
News Archive
Every year waste treatment facilities in the United States process more than eight million tons of semi-solid sewage called biosolids - about half of which is recycled into fertilizer and spread on crop land.
Today in the journal Nature prominent researchers from Canada, Europe and the U.S. have made a powerful call to major funding agencies, asking them to commit to establishing a global genomic data commons in the cloud that could be easily accessed by authorized researchers worldwide.
Politico reports on how Rep. Paul Ryan's record on reproductive issues - including co-sponosring a "personhood amendment" that would declare a fertilized egg to be a person, and voting to defund Planned Parenthood - could widen President Barack Obama's lead among women. Meanwhile, a controversial comment about rape by a GOP candidate running for Senate in Missouri has stirred anger and angst.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed dermatologists view Abbott/Eisai's Humira as the most efficacious therapy for the treatment of moderate to severe psoriasis. Thirty-two percent of surveyed dermatologists selected Humira as the most efficacious, followed by Centocor Ortho Biotech/Merck/Mitsubishi Tanabe's Remicade. The current sales leader Amgen/Pfizer/Takeda's Enbrel was selected as the most efficacious therapy by only 23 percent of dermatologists surveyed.
PRISM Pharma Co., Ltd., a drug discovery company focused on developing small molecule technologies that modulate protein-protein interactions, today announced the close of an approximately $15 million (approximately ¥1.4 billion) Series C financing.
› Verified 6 days ago
| Provider Name | Jola Rzegocki Oconnor |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1669417325 PECOS PAC ID: 7315996931 Enrollment ID: I20220316002879 |
News Archive
Every year waste treatment facilities in the United States process more than eight million tons of semi-solid sewage called biosolids - about half of which is recycled into fertilizer and spread on crop land.
Today in the journal Nature prominent researchers from Canada, Europe and the U.S. have made a powerful call to major funding agencies, asking them to commit to establishing a global genomic data commons in the cloud that could be easily accessed by authorized researchers worldwide.
Politico reports on how Rep. Paul Ryan's record on reproductive issues - including co-sponosring a "personhood amendment" that would declare a fertilized egg to be a person, and voting to defund Planned Parenthood - could widen President Barack Obama's lead among women. Meanwhile, a controversial comment about rape by a GOP candidate running for Senate in Missouri has stirred anger and angst.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed dermatologists view Abbott/Eisai's Humira as the most efficacious therapy for the treatment of moderate to severe psoriasis. Thirty-two percent of surveyed dermatologists selected Humira as the most efficacious, followed by Centocor Ortho Biotech/Merck/Mitsubishi Tanabe's Remicade. The current sales leader Amgen/Pfizer/Takeda's Enbrel was selected as the most efficacious therapy by only 23 percent of dermatologists surveyed.
PRISM Pharma Co., Ltd., a drug discovery company focused on developing small molecule technologies that modulate protein-protein interactions, today announced the close of an approximately $15 million (approximately ¥1.4 billion) Series C financing.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eye Site Of Bluffton Llc 104 Buckwalter Pkwy, Unit 1 C, Bluffton, SC 29910-4131 Ph: (843) 757-9588 | Eye Site Of Bluffton Llc 104 Buckwalter Pkwy, Unit 1 C, Bluffton, SC 29910-4131 Ph: (843) 757-9588 |
News Archive
Every year waste treatment facilities in the United States process more than eight million tons of semi-solid sewage called biosolids - about half of which is recycled into fertilizer and spread on crop land.
Today in the journal Nature prominent researchers from Canada, Europe and the U.S. have made a powerful call to major funding agencies, asking them to commit to establishing a global genomic data commons in the cloud that could be easily accessed by authorized researchers worldwide.
Politico reports on how Rep. Paul Ryan's record on reproductive issues - including co-sponosring a "personhood amendment" that would declare a fertilized egg to be a person, and voting to defund Planned Parenthood - could widen President Barack Obama's lead among women. Meanwhile, a controversial comment about rape by a GOP candidate running for Senate in Missouri has stirred anger and angst.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed dermatologists view Abbott/Eisai's Humira as the most efficacious therapy for the treatment of moderate to severe psoriasis. Thirty-two percent of surveyed dermatologists selected Humira as the most efficacious, followed by Centocor Ortho Biotech/Merck/Mitsubishi Tanabe's Remicade. The current sales leader Amgen/Pfizer/Takeda's Enbrel was selected as the most efficacious therapy by only 23 percent of dermatologists surveyed.
PRISM Pharma Co., Ltd., a drug discovery company focused on developing small molecule technologies that modulate protein-protein interactions, today announced the close of an approximately $15 million (approximately ¥1.4 billion) Series C financing.
› Verified 6 days ago
Michael S Henderson Od Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 167 Bluffton Rd Ste F, Bluffton, SC 29910 Phone: 843-757-7160 Fax: 843-757-8464 | |
Dr. Rinku Navin Patel, OD Optometrist Medicare: Medicare Enrolled Practice Location: 104 Buckwalter Pkwy Ste 1c, Bluffton, SC 29910 Phone: 843-757-9588 | |
Sungate Medical Group Llc Optometrist Medicare: Medicare Enrolled Practice Location: 10 William Pope Dr, Bluffton, SC 29909 Phone: 843-842-2020 Fax: 843-705-1512 | |
Belfair Eye Care Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 18 Oak Forest Rd Ste A, Bluffton, SC 29910 Phone: 843-815-3415 Fax: 843-815-3417 | |
Dr. Nicole Marie Pecko, OD Optometrist Medicare: Medicare Enrolled Practice Location: 19 Promenade St, Bluffton, SC 29910 Phone: 843-815-4343 | |
Dr. Ryan L Crockett, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1050 Fording Island Rd, Bluffton, SC 29910 Phone: 843-227-5530 | |
Kevin Barrows, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4 Bluffton Rd, Bluffton, SC 29910 Phone: 843-815-3891 Fax: 843-815-3897 |